HomeInsulin Degludec And LiraglutideInsulin Degludec And Liraglutide + Nonselective Beta Adrenergic Antagonists

Does Insulin Degludec And Liraglutide Interact with Nonselective Beta Adrenergic Antagonists?

Insulin Degludec And Liraglutide and Nonselective Beta Adrenergic Antagonists have a moderate drug interaction according to U.S. FDA drug labeling data. May increase or decrease blood glucose-lowering effect and may blunt signs/symptoms of hypoglycemia; dosage adjustment and increased glucose monitoring required. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Insulin Degludec And Liraglutide Class
Insulin Analog
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

What To Tell Your Doctor or Pharmacist

If you are taking Insulin Degludec And Liraglutide and your doctor is considering prescribing Nonselective Beta Adrenergic Antagonists (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Insulin Degludec And Liraglutide(Xultophy 100/3.6)+💊 Nonselective Beta Adrenergic Antagonists

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Insulin Analog
Drug B class
Source
NLP:insulin degludec and liraglutide

What this means in plain English

May increase or decrease blood glucose-lowering effect and may blunt signs/symptoms of hypoglycemia; dosage adjustment and increased glucose monitoring required.

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Insulin Degludec And Liraglutide and Nonselective Beta Adrenergic Antagonists against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.